ACADIA Pharmaceuticals (ACAD)
15.14
-0.06 -0.39%
NASDAQ
Apr 26, 13:35
Delayed 2m
USD
View All Key Stats
ACAD Key Stats
| Income Statement | |
| Revenue (TTM) | 124.90M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.35 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -289.40M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 94.36% |
| Profit Margin (Quarterly) | -158.1% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 1.888B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 14.86 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 5.631 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -29.90M |
| Return on Equity (TTM) | Upgrade |
View All ACAD News
ACAD News
-
WireHeadlineTime (ET)
-
MT Newswires04/25 16:27
-
Yahoo04/25 15:53
-
Yahoo04/25 15:19
-
SA Breaking News04/25 15:16
-
MT Newswires04/25 15:07
-
Yahoo04/25 14:53
-
PR Newswire04/24 12:32
-
Yahoo04/23 10:32
-
Business Wire04/23 09:00
-
Yahoo04/20 14:45
View All Events
ACAD Events
| Date | Type | Description |
|---|---|---|
| 05/09/2018 | Misc | ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/09/2018 | Earnings | ACADIA Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 02/27/2018 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
| 02/27/2018 | Earnings | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Results in 2017 |
| 01/09/2018 14:00 PDT | Misc | ACADIA Pharmaceuticals Q&a Session at the 36th Annual j.p. Morgan Healthcare Conference |
| 11/07/2017 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 11/07/2017 | Earnings | ACADIA Pharmaceuticals Inc Third Quarter Earnings in 2017 Release |
| 08/08/2017 17:00 EDT | Misc | ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017 |
| 08/08/2017 | Earnings | ACADIA Pharmaceuticals Inc Second Quarter Earnings in 2017 Release |
| 06/13/2017 | Misc | ACADIA Pharmaceuticals Inc Annual General Meeting in 2016 |
ACAD Fundamentals
Income Statement View Statement
ACAD Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ACAD One Page Reports
- One Page Report Download
ACAD Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 15.14 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.acadia-pharm.com
- Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: May. 09, 2018
- Last Earnings Release: Feb. 27, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. It aims to discover small molecule drugs to address Parkinson’s, Alzheimer’s and schizophrenia.
ACAD Excel Add-In Codes
- Name: =YCI("ACAD","name")
- Description: =YCI("ACAD","description")
- Sector: =YCI("ACAD","sector")
- Industry: =YCI("ACAD","industry")
- Est. Current Fiscal Year End: =YCI("ACAD","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ACAD Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ACAD Tweets Stocktwits
Advertisement
